About Bioline
Bioline is a company based in London (United Kingdom) founded in 1992 was acquired by Meridian Bioscience in July 2010. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 42 employees as of October 31, 2019. Bioline offers products and services including SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases. Bioline operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter London, United Kingdom
- Employees 42 as on 31 Oct, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Meridian Bioscience
-
Annual Revenue
$68.23 M (USD)314as on Sep 03, 2020
-
Net Profit
$39.17 M (USD)686as on Sep 03, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
42
as on Oct 31, 2019
-
Acquired by
Meridian Bioscience
(Jul 20, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioline
Bioline offers a comprehensive portfolio of products and services, including SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases.
Reagents for fast and sensitive qPCR applications are provided.
Library preparation kits for NGS sequencing are offered.
DNA polymerases for robust PCR amplification are supplied.
Funding Insights of Bioline
Investors in Bioline
Bioline has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular diagnostic device and kits
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioline
Financial Statements - Bioline
Bioline Comparisons
Competitors of Bioline
Bioline operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Frequently Asked Questions about Bioline
Bioline was founded in 1992.
Bioline is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Oct 31, 2019, the latest employee count at Bioline is 42.
Annual revenue of Bioline is $68.23M as on Sep 03, 2020.
Bioline, a part of Meridian Bioscience, is focused on the development and supply of reagents for molecular biology applications. Products are designed for PCR, qPCR, and next-generation sequencing, supporting research in areas such as agricultural biotechnology, cancer research, drug discovery, epigenetics, molecular diagnostics, and stem cell research. Solutions are offered to facilitate gene expression analysis, genotyping, biomarker analysis, and nucleic acid purification across various scientific sectors.
Bioline's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Bioline offers SensiFAST™ Kits, JetSeq™ Kits, and MyTaq™ Polymerases.
Bioline has 1 investor. Key investors include Meridian Bioscience.